Cohance Lifesciences Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 372.05 | 566.76 | 487.70 |
| Operating Expense | 333.40 | 467.49 | 383.66 |
| Net Profit | 1.41 | 34.56 | 47.29 |
| Net Profit Margin | 0.38% | 6.10% | 9.70% |
| Earning Per Share | 0.04 | 0.90 | 1.24 |
| EBIDTA | 37.85 | 98.47 | 98.56 |
| Effective Tax Rate | 0% | 21.24% | 12.17% |
Particulars
Jun 2026
Revenue372.05
Operating Expense333.40
Net Profit1.41
Net Profit Margin0.38
Earning Per Share0.04
EBIDTA37.85
Effective Tax Rate0
